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Amino acids are a group of metabolites that are important substrates for protein synthesis, are important as
signaling molecules and play central roles as highly connected metabolic hubs, and therefore, there are many
reports that describe disease-specific abnormalities in plasma amino acids profile. However, the causes of
progression from a healthy control to a manifestation of the plasma amino acid changes remain obscure. Here, we
extended the plasma amino acids profile to relationships that have interactive properties, and found remarkable
differences in the longitudinal transition of hyperglycemia as a diabetes emergency. What is especially important is
to understand pathogenesis for better treatment and early diagnosis of diabetes. In this study, we performed
interactive analysis using time course data of the plasma samples of AKITA mice, which develop hyperglycemia.
Primarily, we decided to analyze the interactive property of amino acids which had highly significant association
with hyperglycemia, namely alanine, glycine, leucine, isoleucine and valine. Next, we inferred the interactive
network structure, which reproduces the actual time course within an error allowance of 10% using an S-system
model (a conceptual mathematical model for analyzing and simulating networks). The emphasis of this study was
altered interactions of plasma amino acids that show stabilizing and destabilizing features in a variety of clinical
settings. By performing sensitivity analysis, the most dominant relations in this network were selected; the control
paths from glycine to isoleucine in healthy control and from alanine to glycine in hyperglycemia. This result is in
good agreement with the biological knowledge regarding branched-chain amino acids, and suggests the biological
importance of the effect from alanine to glycine.
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Observations of metabolic profiles have suggested the pos-
sibility of representing biological states and reflect changes
in metabolic endogenous homeostasis that are induced
by diseases (Raamsdonk et al. 2001; Brindle et al. 2002;
Nicholson and Wilson 2003; Allen et al. 2003; An et al.
2004; Sreekumar et al. 2009). This approach is based on
the fact that the amounts of the metabolites in biological
fluids and tissues change in coordination with the physio-
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have revealed that these metabolic profiles contain pheno-
typic information that can be used as a signature for a
physiological condition. From the viewpoint of metabolic
networks in biological systems, amino acids are a group of
metabolites that are important substrates for protein syn-
thesis, are important as signaling molecules and play cen-
tral roles as highly connected metabolic hubs (Felig 1975;
Jeong et al. 2000). There are some reports that describe
disease-specific abnormalities in plasma amino acid pro-
files, such as liver failure (Fischer et al. 1975; Soeters and
Fischer 1976), obesity and diabetes, which could reflect
metabolic modulation induced by insulin resistance (Felig
et al. 1969; Felig et al. 1970; Wang et al. 2011). There are
some trials that make use of plasma amino acid profiles to
diagnose and distinguish abnormal subjects from healthy
subjects or subtypes and stages of diseases (Noguchi et al.n Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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amino acid profiles for diagnostic markers is Fisher’s ratio,
which is a ratio of branched-chain amino acids to aro-
matic amino acids and is used as a diagnostic marker for
liver fibrosis (Soeters and Fischer 1976). These studies
clearly indicate that the plasma amino acid profile itself
can be a useful tool for monitoring the physiological state
of an organism.
Although these previous studies discuss how to distin-
guish different physiological states using the plasma amino
acid profile data, the control mechanism behind the
change in the profile is not discussed in detail. Therefore,
conventional investigations have room for improvement at
determining why the plasma amino acid profiles change in
accordance with the physiological state and which amino
acid is the trigger to shift from a healthy control to a
manifestation.
To solve this problem and understand the interactive
mechanism that controls the plasma amino acid concen-
trations under physiological conditions, an analysis of
the interactive properties of the network is necessary.
In the interactive modeling approach, various network
analysis models are proposed. The advantage of the un-
derstanding of the interaction between these system
components by network analysis is to be able to infer
the interrelated and directional network structure of the
system components without considering any prior topo-
logical information. This analysis should lead us to fur-
ther understand the interaction of the profiles of system
components and provide some clues for the factors that
affect the interrelated network under various physio-
logical conditions. Using the time courses of the data,
the interactive network structure was investigated using
the S-system analysis method (Savageau 1976; Maki
et al. 2004; Shikata et al. 2010; Somogyi and Sniegoski
1996; Savageau 1998; Maki et al. 2001; Kikuchi et al.
2003). The S-system is one of the best formalisms for es-
timating the interactive mechanisms among the system
components and enables us to reconstruct the network
architectures with the experimentally observed time
courses of the quantities of the network components. Its
greatest appeal is its simpler two-term format, which
leads to unusual mathematical opportunities, which we
will discuss later. In particular, the steady state of an S-
system can be computed with methods of linear algebra,
whereas other formats require more complicated methods
(Mueller et al. 1998; Savageau 1993). Maybe surprisingly,
the S-system format is also the more accurate representa-
tion for functions with a hyperbolic shape, that is, functions
that start at a small value and monotonically grow toward
saturation, such as a Michaelis-Menten rate function.
In this study, we performed interactive network ana-
lysis while using time course data of the plasma samples
of AKITA mice, which develop hyperglycemia, and theanalytical method based on the S-system model. Further-
more, we performed sensitivity analysis for each interre-
lated control path in the network model and determined
which paths or relations between amino acids are domin-
ant in maintaining the network structure.
Results
Time course data of the experimental measurements and
calculations in Ins2+/+ and Ins2+/−
The time courses of the blood sugar (BS) and the plasma
amino acids are shown in Figure 1. At 3 weeks of age, BS
was not different between a mouse model of hyperglycemia
(Ins2+/−) and a mouse model of healthy control (Ins2+/+).
The Ins2+/− BS had started to become elevated by 4 weeks
of age. It continued to elevate until about 7 weeks of age.
After that, there was little BS change in Ins2+/−. On the
other hand, the Ins2+/+ BS hardly changed until 20 weeks
of age. As compared with Ins2+/+, BS was significantly
higher in the Ins2+/− mice after 4 weeks of age (Figure 1).
In comparison with Ins2+/+, the plasma concentrations of
isoleucine, leucine, valine, alanine, citrulline, phenylalanine,
proline and histidine were significantly higher and those of
glycine, glutamine, glutamate and asparagine were signifi-
cantly lower in Ins2+/− mice (P < 0.01, age-by-genotype
interaction). In association with continuous hyperglycemia,
isoleucine, leucine, valine, alanine and glycine showed top-
ranked correlations with BS in plasma amino acids (Table 1).
As shown in Figure 1 and Table 1, isoleucine, leucine, val-
ine, alanine and glycine showed the significant difference of
the longitudinal change between Ins2+/+ and Ins2+/− and
top-ranked correlation with BS in plasma amino acids,
which indicated that the longitudinal changes in these
plasma amino acids had highly significant association with
hyperglycemia. In comparison with Ins2+/+, food intake
was lower in Ins2+/− at 12 weeks of age (P < 0.05). Weight
was significantly lower in Ins2+/− mice after 15 weeks age
(P < 0.05, age-by-genotype interaction) (Figure 2).
In Ins2+/+ (Figure 3A), the concentration of alanine, leu-
cine, isoleucine and valine slightly fluctuated throughout
the experimental period. A decrease in the concentration of
glycine was observed in week 3. By week 9, this concentra-
tion was decreased by approximately one-third of the con-
centration measured before the experiment. In Ins2+/−
(Figure 3B), the concentration of alanine, leucine, isoleucine
and valine fluctuated slightly and gradually increased more
than those of the Ins2+/+ throughout the experimental
period. A decrease in the concentration of glycine was ob-
served in week 3. By week 9, this concentration was de-
creased by approximately half of the concentration
measured before the experiment.
Optimization of the parameter set
Using the time courses of the data described above, the
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Figure 1 The changes in BS and plasma amino acids in Ins2+/+ and Ins2+/−. Line graph for the change in the fasting BS and representative
plasma amino acids from 3 to 20 weeks of age. To compare the change in the fasting BS and plasma amino acids between the Ins2+/− and Ins2+/+
mice, statistical analysis was performed using two-way ANOVA, and Bonferroni correction was used for the post hoc test. Data are the mean ± standard
error of the mean. The solid line indicates Ins2+/− (n = 9–13). The dotted line indicates Ins2+/+ (n = 8–12). * p < 0.05, ** p < 0.01, Ins2+/− vs. Ins2+/+.
This figure was revised based on our previous study (Mochida et al. 2011).
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is one of the best formalisms for estimating the interaction
mechanisms among the system components and enables
us to reconstruct the network architectures with the ex-
perimentally observed time courses of the quantities of
the network components. The inference of the interactive
network structure is achieved by optimizing the S-system
parameter set. For the evaluation of the network structure
defined by each parameter set, the average relative error
between the calculated value and experimental value persampling point was computed, and the network model
that gave the least average error was evaluated highly.
After 50 trials of optimization by the genetic algorithm
described in the Methods section, one network model was
selected in each group; this network model had a structure
that reproduced the experimentally obtained time courses
with the smallest average relative error. The obtained
parameter set of this model is shown in Table 2; there, the
interrelated coefficient of each path in the network is in-
dicated as a matrix, in which the amino acid giving the
Table 1 Pearson’s correlation coefficients between the BS
and the plasma amino acids

























Pearson’s correlation coefficients were used to evaluate the correlations
between the BS and the plasma amino acids of the time-courses.
Figure 2 Food intake and the changes in weight in Ins2+/+ and Ins2+
axis indicates the food intake (g/day). The horizontal axis indicates the age (w
The black bar indicates Ins2+/− (n = 3). Food intake was lower in Ins2+/−. *p <
to 20 weeks of age. The vertical axis indicates the body weight (g). The horizo
indicates Ins2+/− (n = 9–13). The dotted line indicates Ins2+/+. (n = 12). * p <
previous study (Mochida et al. 2011).
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(i) receiving the effect is indicated in the left column. For
each network component which is an amino acid (Xi), the
non-negative parameters αi and βi determine relative in-
flow and outflow of Xi. The terms gij determine the inter-
active affectivity of amino acid Xj to amino acid Xi gij
represents the interrelated coefficient of Xj to the synthesis
of Xi. The terms hii determine the interactive affectivity of
amino acid Xi to amino acid Xi; hii represents the interre-
lated coefficient of Xi to the degradation of Xi. In this case,
the value of other hii (i ≠ j) was assumed to be 0. The num-
ber of estimated parameters in this S-system formalism is
n × (n + 3), where n is the number of state variables (Xi).
This network model reproduced the actual time course
with an average error of 7.37% in Ins2+/+ and 6.63% in t
Ins2+/− (Figure 3A and B). The same network model is vi-
sualized as a network figure in Figure 4A and B. In the
interactive network (Figure 4A and B), sign reversal of the
interrelated coefficient was observed in valine to alanine,
leucine to alanine, isoleucine to alanine, alanine to isoleu-
cine and glycine to valine between Ins2+/+ and Ins2+/−.
However, the dynamic range of the interrelated coefficient
was maintained not only with the common network struc-
ture of Ins2+/+ and Ins2+/− but also with the network
structure of Ins2+/+ in a direction opposite to Ins2+/−.
Sensitivity analysis
For the parameter set of the network model shown in
Table 2, we performed sensitivity analysis. The sensitivity
of each parameter is evaluated by adding a 5% error to
the estimated value of the parameter and quantifying the
difference that is generated over the time course. Larger
differences more strictly regulate the parameter; thus,
the parameters that cause large differences are dominant
in determining the network structure. For convenience/−. A. Bar graph for the food intake in Ins2+/− and Ins2+/+. The vertical
eek). Data are the mean ± SEM. The white bar indicates Ins2+/+ (n = 3).
0.05, Ins2+/− vs. Ins2+/+. B. Line graph for the change in weight from 3
ntal axis indicates the age (week). Data are means ± SEM. The solid line
0.05, ** p < 0.01, Ins2+/− vs. Ins2+/+. This figure was revised based on our
Figure 3 Plasma amino acid time-course calculated using the parameter set in Table 2. The experimentally measured concentrations of
each amino acids from 3 to 20 weeks of age are indicated with symbols and the calculated bold lines were obtained with the estimated
parameters shown in Table 2. A. Time-course data of the experimentally measured and that of the calculated in Ins2+/+. B. Time-course data of
the experimentally measured and that of the calculated in Ins2+/−.
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to relative values, with the highest value being 100.
The relative sensitivity of each parameter in the net-
work model is shown in Figure 4C and D. The most
dominant interactions were the positive effect of glycineTable 2 The parameter set defining the interactive network m
(Ins2+/+, Ins2+/−) gij
j
i α Val Leu Ile Ala
Val (1.5, 4.4) (0, 0) (−0.2, -0.7) (0, 0) (2.0, 0.6)
Leu (7.5, 4.8) (0, 0) (0, 0) (0, 0) (−1.3, -1.0)
Ile (7.6, 3.8) (0, 0) (−0.1, -1.3) (0, 0) (−2.3, 0.4)
Ala (7.4, 4.6) (0.8, -0.6) (−1.7, 1.0) (2.6, 0.9) (0, 0)
Gly (8.8, 2.8) (2.4, 1.2) (−2.3, -1.1) (−1.9, -1.5) (2.1, 1.7)
The interrelated coefficient of each path in the network model (left: Ins2+/+, right:
(j) is indicated in the top row and the amino acid receiving the effect (i) is indicated
amino acids, and hij indicates the speed of degradation for each amino acid. The pa
amino acids.on isoleucine in the Ins2+/+ (Figure 4C) and positive effect
of alanine on glycine in Ins2+/− (Figure 4D). As shown in
Figure 4C and D, the value of the relative sensitivity and
differences between the top-ranked and other sensitive pa-
rameters of the Ins2+/+ are smaller than those of Ins2+/−.odel
hij
j
Gly β Val Leu Ile Ala Gly
(−1.8, 0.1) (1.0, 1.5) (0, 0.01) (0, 0) (0, 0) (0, 0) (0, 0)
(1.4, 1.2) (1.2, 1.0) (0, 0) (0, 0) (0, 0) (0, 0) (0, 0)
(2.5, 0.8) (1.1,1.5) (0, 0) (0, 0) (0, 0) (0, 0) (0, 0)
(−0.9, -1.1) (1.2, 1.5) (0, 0) (0, 0) (0, 0) (0.7,0) (0, 0)
(0, 0) (1.2, 5.6) (0, 0) (0, 0) (0, 0) (0, 0) (1.3, 0.8)
Ins2+/−) is indicated as a matrix in which the amino acid giving the influence
in the left column. The variable gij indicates the effect between each pair of
rameters with value 0 indicate that there is no relationship between the two
Figure 4 The network model defined by the parameter set in Table 2. The arrows indicate positive effects, and the lines with bars indicate
negative effects. The numbers adjacent to the lines indicate the interrelated coefficient of each path. Red arrows and lines with bars indicate the
difference between Ins2+/+ and Ins2+/−. A. Ins2+/+ network model defined by the parameter set in Table 2. B. Ins2+/− network model defined
by the parameter set in Table 2. Relative sensitivity of each of the parameters in the network model. The arrows indicate positive effects from
amino acids on the left to amino acids on the right, and the bars indicate negative effects from amino acids on the left to amino acids on the
right. C. Ins2+/+ relative sensitivity of each of the parameters in the network model. D. Ins2+/− relative sensitivity of each of the parameters in
the network model.
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positive effect of glycine to isoleucine in Ins2+/− dropped
drastically and that of alanine to glycine increased with the
relative sensitivity, as shown in Figure 4D.Discussion
Metabolism can be viewed as a network that can
become perturbed during disease and physiologic in-
sults. In addition to the metabolic pathway map within
cells, there are various levels of networks within the
body, e.g., the transport of substrates such as amino
acids in the blood, moving between organ systems,
which represents one level.
With the time course data of the plasma amino acid
concentrations obtained under Ins2+/+ and Ins2+/−, aninteractive network model was inferred in the form of
an S-system differential equation model. The network
model could reproduce the experimentally obtained time
courses of the plasma amino acids with an average error
of 7.37% in Ins2+/+ and 6.63% in the Ins2+/− (Figure 3).
The size of the analytical experimental error estimated
with the coefficient of variation (Cv) was 10.07% in this
experiment. Because the average error for the network
model is smaller than the analytical error, we presumed
that the model reproduced the experimental time course
within the permissible error range.
The concentration of isoleucine, leucine, valine, ala-
nine and glycine was shown to be different in terms of
the longitudinal changes between Ins2+/+ and Ins2+/−
and showed top-ranked correlation with BS in plasma
amino acids (Figure 1 and Table 1). The biological
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amino acid profiles can be partly understood based on
metabolic shifts resulting from a catabolic shift in pro-
tein metabolism and upregulated gluconeogenesis
(Chevalier et al. 2006), partly because food intake and
weight of Ins2+/− were lower than those of Ins2+/+
(Figure 2). After 15 weeks of age, that is to say after the
onset of hyperglycemia, weight was significantly lower
in the Ins2+/− as compared with Ins2+/+. Moreover,
the plasma insulin of Ins2+/− tends to be lower than
that of Ins2+/+ (Mochida et al. 2011). Altered plasma
amino acid levels could be explained by enhanced pro-
tein catabolism associated with the lower insulin level.
Although it would be necessary to measure a catabolism-
related marker. The metabolic state of hyperglycemia is
closely related to the pathophysiological state of metabolic
syndrome associated with diabetes (Després and Lemieux
2006). In a recent study on metabolic profiles predicting
diabetes, several amino acids, including branched-chain,
showed significant associations with future occurrences of
diabetes (Wang et al. 2011). It is interesting to point out
the close relationship between this study in human and
ours in AKITA mice and the importance of amino acid
profiles in predicting future diabetes and diagnosing
existing hyperglycemia, although the study design and tar-
get were different.
Our results showed significant differences in plasma
amino acids in accordance with the degree of hypergly-
cemia. We found that there were higher levels of
branched-chain amino acids and alanine in Ins2+/−, while
there were lower levels of glycine. These observations have
some relation with the sign reversal of the interrelated co-
efficient in valine to alanine, leucine to alanine, isoleucine
to alanine, alanine to isoleucine and glycine to valine be-
tween Ins2+/+ and Ins2+/− (Figure 4A and B). Metabolic
alterations, such as the sign reversal of the interrelated co-
efficient, could contribute to altered amino acid levels in
response to hyperglycemia.
From the sensitivity analysis, the parameters in the net-
work were ranked by their dominance in determining the
network structure. As shown in Figure 4C and D, the most
dominant interaction was the positive effect of glycine to
isoleucine in Ins2+/+ and positive effect of alanine to gly-
cine in Ins2+/−. In the values for sensitivity, the difference
between the top-ranked and other sensitive parameters of
Ins2+/+ is smaller than that of Ins2+/−. What is notable is
that the sensitivity of Ins2+/− is concentrated in the posi-
tive effect of alanine to glycine. Therefore, it is expected
that Ins2+/− regulates the sensitivity of the kinetic param-
eters more intensively than Ins2+/+, and certain relations
between amino acid concentrations are specific for certain
physiological phenomena; thus, individuals whose physio-
logic states are different could have a different pattern in
the network structure that follows (Noguchi et al. 2006).The positive effect of glycine to isoleucine was the
most dominant interaction in the network model for
Ins2+/+ (Figure 4C). There are some observations with
this relationship. It has been reported that increased
branched-chain amino acids, including isoleucine, could
contribute to increased gluconeogenesis and glucose in-
tolerance via the transamination of pyruvate to alanine
(Newgard et al. 2009). In addition, increases in alanine,
a highly gluconeogenic amino acid, activate the glycine–
pyruvate metabolic linkage. Two of the most dominant
interactions that had a relative sensitivity over 50% in
the Ins2+/+ had a positive effect of glycine to isoleucine
and positive effect of isoleucine to alanine (Figure 4C).
Compared with the Ins2+/+ in Figure 4C, the rank of
the positive effect of glycine to isoleucine and that of
isoleucine to alanine in Ins2+/− dropped drastically
with the relative sensitivity, as shown in Figure 4D. The
sensitivity of the target kinetic parameter in Figure 4C
and D can be evaluated by the total amount of differ-
ence between the experimentally measured time courses
of the target reactants and the calculated values for the
case of % change in the value of the target kinetic param-
eter. The higher the sensitivity, the more strictly regulated
the parameter; thus, the parameters that have a high sensi-
tivity are dominant in determining the network structure.
Thus, as shown in Figure 4C, the first and second top-
ranked sensitive parameters in the Ins2+/+ (the positive
effect of glycine to isoleucine and isoleucine to alanine,
respectively) are assumed to play a role in preventing
hyperglycemia; however, as shown in Figure 4D, the sen-
sitivity of these two parameters has drastically decreased
in ranking, and the positive effect of alanine to glycine
has alternatively increased in ranking. Therefore, it is
expected that this switch in sensitivity is the trigger to
the shift from the healthy control to hyperglycemia.
The positive effect of alanine to glycine in Ins2+/− can be
explained by upregulated gluconeogenesis (Figure 4D). In
terms of metabolic mechanisms, glycine and alanine are
typical glucogenic amino acids. Relevant metabolic path-
ways generate glucogenic metabolites in the tricarboxylic-
acid cycle and also via the glycine–pyruvate metabolic link-
age and alanine shuttle in gluconeogenesis. Alanine is
known to be a major gluconeogenic precursor. It has been
reported that alanine increased in Ins2+/−, and the BS itself
was the most important factor related to the alanine metab-
olism rather than insulin secretion (Robert et al. 1985;
Shulman et al. 1980). It has been reported that in hepato-
cytes, glucose production from glycine increases in dia-
betic individuals, while this type of glucose production
is low under healthy conditions (Hetenyi et al. 1988).
Glycine is synthesized from glycolytic intermediates via
3-phosphoglycerate dehydrogenase, which is an NAD-
linked enzyme that converts 3-phosphoglycerate to 3-
phosphohydroxypyruvate (Noguchi et al. 2008).
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creased demand for glycerol and glyceride for triglycer-
ide synthesis can affect glycine levels in the peripheral
circulation.
When the concentration of alanine increases, the de-
mand for glycerol and glyceride for triglyceride synthesis
also increases, which accelerates glyceroneogenesis and
activates the glycine–pyruvate metabolic linkage. Thus,
the concentration of alanine has a positive effect on con-
centrations of glycine. In view of the positive effect of ala-
nine to glycine in Ins2+/− compared with the Ins2+/+, as
shown in Figure 3A, it is expected that the concentration
of alanine and glycine increase with Ins2+/−, as shown in
Figure 3B. In contrast to expectation, the concentration of
glycine decreases. However, the concentration of alanine
increases as expected. In Ins2+/−, it is assumed that the
supply of glycine and alanine is upregulated, and the
utilization of glycine is much more upregulated than its
supply. This result demonstrates the advantage of applying
network analysis to plasma amino acid data when deter-
mining the interactive mechanism, such as the balance be-
tween the supply and utilization of plasma amino acids in
accordance with the physiological state.
Metabolic changes in amino acids can be better under-
stood as a catabolic shift in protein metabolism and
upregulated gluconeogenesis that is induced by the insu-
lin secretory response. Although our analysis did not
consider any topological information on amino acid me-
tabolism and was completely data-driven, interactions
determined to be dominant by systems analysis and sen-
sitivity analysis are well-known interactive relations in
glyceroneogenesis. This fact indicates that our analytical
methods are useful in finding the important relations be-
tween amino acids with and without any prior know-
ledge of the amino acid metabolism. It also indicates
that the positive effect of glycine to isoleucine and that
of alanine to glycine, which were selected with the same
analytical procedure, might have some physiologically
important function.
Conclusions
We have shown an attempt to explore interactive mech-
anisms of plasma amino acids subjected to physiological
properties of the longitudinal transition in a mouse
model of hyperglycemia. On the basis of these ap-
proaches, it might be able to show that, in the combin-
ation with experimental data, computational biology
has clear added value and that on the basis of the find-
ings a number of expected results can be extracted from
the network analyses as well. In this study, we demon-
strated the advantage of applying network analysis to
plasma amino acid data for constructing a hypothesis
about why the plasma amino acid profiles change in ac-
cordance with physiological states.Methods
Animals, experimental design and sample collection
We used male mice that were obtained by mating male
and female heterozygous C57BL/6-Ins2 AKITA/J mice
purchased from the Jackson Laboratory in Bar Harbor,
Maine, USA. Experimental procedures for the treatment
of the mice were approved by the Center for Animal Re-
sources and Development (CARD) of Kumamoto Uni-
versity. Animal care was performed as outlined in the
Guide for the Care and Use of Laboratory Animals. The
AKITA mouse has a missense mutation of the insulin 2
gene (Ins2). This mutation is inherited in an autosomal
dominant manner. Homozygous male mice (Ins2−/−)
develop hyperglycemia by 2 weeks of age (Kayo and
Koizumi 1998). All Ins2−/− mice displayed hypergly-
cemia at 3 weeks of age. Ins2−/− mice were excluded
from this study because their plasma amino acids could
not be determined before the increase in BS. The wild
type male mice (Ins2+/+) (n = 8–12) do not develop
hyperglycemia (Kayo and Koizumi 1998). Heterozygous
male mice (Ins2+/−) (n = 9–13) develop hyperglycemia
between 4 and 8 weeks of age (Oyadomari et al. 2002).
The development of hyperglycemia is not associated
with either obesity or insulitis but is associated with
pancreatic β-cell dysfunction (Wang et al. 1999). Dia-
betic complications manifest in the Ins2+/− mice until
20 weeks of age (Haseyama et al. 2002; Hong et al. 2007;
Schmidt et al. 2009).
Starting from 3 weeks of age, mice were maintained
on a 12:12-h light–dark cycle, with water provided
freely. The composition of the diet was based on a CE-
2 (Clea Japan, Inc., Tokyo, Japan) standard diet under
ad libitum feeding conditions. Between 3 to 20 weeks
of age, blood samples were collected from the tail vein.
After the body weight measurement, we performed
blood sampling from 11:00 to 12:00 after fasting for
2 hours once every week, and we measured the BS and
plasma amino acids in the mice.
For the blood sampling, the mice were anesthetized
with 3% isoflurane. The blood samples were collected
with capillaries (Ringcaps; Hirschmann Laborgeraete
GmbH & Co. KG., Germany) containing EDTA-2Na
and kept in a tube at 4°C. The amount of blood was
100 μL for the mice that were more than 5 weeks of age
and 75 μL for the mice that were less than 4 weeks of age.
Fasting BS was determined by the immobilized enzyme
electrode method (Glutest Ace R; Arkray Factory, Inc.,
Japan). For the extraction of the plasma sample, the col-
lected blood was centrifuged at 1500 × g for 10 minutes at
4°C. The plasma samples were kept at −80°C until the
plasma amino acids were measured. The amino acids were
measured using high-performance liquid chromatography-
electrospray ionization mass spectrometry (Shimbo et al.
2009a, 2009b).
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Variables were expressed as mean ± standard error of the
mean. To compare the longitudinal change, statistical ana-
lysis was performed using two-way ANOVA, and
Bonferroni correction was used for the post hoc test. To
evaluate the correlations between the BS and plasma
amino acids, pearson’s correlation coefficients were calcu-
lated. To compare the food intake between Ins2+/+ and
Ins2+/−, statistical analysis was performed using Student's
t-test.Interactive network analysis
We analyzed the interactive properties of amino acids
which had highly significant association with hypergly-
cemia showing the significant difference of the longitu-
dinal change between Ins2+/+ and Ins2+/− and top-
ranked correlation with BS in plasma amino acids.
In the interactive network analysis, the interrelated
coefficients between the amino acids were first deter-
mined, and then, each path was subjected to sensitivity
analysis for its dominance in maintaining the network
structure.S-system analysis method
The S-system belongs to the type of power-law formal-
ism in which the component processes are expressed by













j ; ‐‐‐‐‐‐ ð1Þ
where n is the total number of state variables or network
components (Xi), and i and j (1 ≤ i, j ≤ n) are suffixes of
state variables. The terms gij and hij are the interactive
affectivity of Xj to Xi; gij (hij), which represents the inter-
related coefficient of Xj to the synthesis (degradation) of
Xi. Thus, the first term of the equation represents all of
the influences that increase Xi, whereas the second term
represents all of the influences that decrease Xi. In a net-
work context, the non-negative parameters αi and βi are
called the relative inflow and outflow, respectively, of
network component Xi, and real-valued exponents gij
and hij are referred to as the interrelated coefficients be-
tween components Xj and Xi, respectively.
To infer the network model, the parameters αi, βi, gij
and hij must be optimized. In this optimization problem,
each set of parameter values to be estimated is evaluated
using the following procedure: suppose that Xcali;t is the
numerically calculated time course of the state variable
Xi at time t and that X
exp
i;t represents the experimentallyobserved time-course of Xi at time t. We sum the rela-












where N is the total number of experimentally observable
state variables, and T is the total number of sampling
points over time in one experimental condition. The com-
putational task is to determine a set of parameter values
that minimizes the objective function E within a given
error allowance.
For the optimization of a large number of real-valued
parameters, the computational technique based on
real-coded genetic algorithms (RCGA) (Nakatsui et al.
2008; Ono and Kobayashi 1997; Ueda et al. 2002) is
introduced as a nonlinear numerical optimization
method that is much less likely to become stuck in a
local minimum. This technique is based on a combin-
ation of UNDX (Ono and Kobayashi 1997) and an alter-
ation of the MGG model (Sato et al. 1997). The
genome (design code) of each individual (each set
of parameter values) is shown in Figure 5. A genome
(corresponding to one individual) contains a set of
S-system parameters (n αi s and βi s and n × n gij s and
hij s), which form an n × (2n + 2) matrix. An individual
represents one S-system model. Each small square in
Figure 5 corresponds with each parameter that has a
real value.Parameter optimization
The interactive analysis was performed using amino acids
which had highly significant association with hypergly-
cemia showing the significant difference of the longitu-
dinal change between Ins2+/+ and Ins2+/− and top-
ranked correlation with BS in plasma amino acids. The ex-
perimental time-courses were obtained for Ins2+/+ and
Ins2+/− as described above.
When calculating the time-course for each candidate
parameter set and evaluating the average relative error
from the experimental data, the measured time courses
of the plasma amino acids were given for each experi-
mental condition.
The calculation with the genetic algorithm was per-
formed with a population of 300 in one generation, and
one trial with 50,000 generations was repeated 50 times.
From the last generation of each trial, the parameter set
with the network structure consistent with the least aver-
age relative error between the calculated value and experi-
mental value per sampling point was selected as the
candidate network model, and from 50 candidates, one
parameter set with the least average error was selected as
Figure 5 The scheme of interactive network analysis using the S-system. First, the time course data were obtained, and the S-systems
analysis was performed, calculating the time-courses for each parameter set using a real-coded genetic algorithm and evaluating the average
relative error from the experimental data. Finally, the inferred network model was verified for its applicability to simulating other time courses.
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was subjected to the next sensitivity analysis.Sensitivity analysis method
To analyze the importance of each interrelated path in
the estimated network, we evaluated the sensitivity of
each parameter in the network. If the sensitivity of a
certain parameter is high, then the corresponding path
must be essential or rigid for realizing the experimen-
tally observed time courses.
We added a 5% perturbation to each interrelated co-
efficient, gij or hij, in the network and the relative
squared error between the calculated time course data
before adding perturbations, and the result after
adding the perturbations was evaluated. Here, wedefined the evaluated value of the sensitivity Sgij (Shij)
for the interaction coefficient gij (hij) as follows:











where CALd,i,t shows the numerically calculated time
course before adding a 5% perturbation at time t of the
state variable Xi in the d-th data set, and PERd,i,t shows
the results after adding a 5% perturbation at time t of
the state variable Xi in the d-th data set. D is the
amount of the time course data, N is the number of
variables, and T is the number of sampling points in
each time course. For convenience of comparison, we
performed scaling such that the highest evaluated
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http://www.springerplus.com/content/2/1/287value on the network candidate was 100, and other
scores are expressed as the ratio to the highest value.
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